Hermetica Superfood Encyclopedia
The Short Answer
Euphorbia ingens latex contains ingenane-type diterpene esters — including Euphorbia factors I1, I5, and I6 — that activate protein kinase C (PKC) to exert irritant, antiproliferative, and potential antiviral effects at the cellular level. Preclinical data show an ethyl acetate fraction achieving an IC50 of 9.71 ± 0.4 µg/mL against cancer cell lines with a selectivity index of 8.26, though no human clinical trials have been conducted and the high toxicity profile severely limits therapeutic application.
CategoryHerb
GroupAfrican
Evidence LevelPreliminary
Primary KeywordEuphorbia ingens medicinal uses
Ku Tim — botanical close-up
Health Benefits
**Antiproliferative Activity**: The ethyl acetate fraction of E
ingens demonstrates an IC50 of 9.71 ± 0.4 µg/mL against cancer cell lines in vitro, with a selectivity index of 8.26, suggesting selective cytotoxicity against malignant versus normal cells via uncharacterized intracellular pathways.
**Wound and Infection Management (Traditional)**
Latex has been applied topically in African ethnomedicine to treat wounds and skin infections, likely leveraging its broad antimicrobial properties; however, rigorous clinical validation is entirely absent and its caustic nature poses significant dermal risk.
**Potential Antiviral Effects**
Ingenol ester fractions from closely related Euphorbia usambarica reactivate latent HIV-1 in cell assays at 10–100 µg/mL via PKC-mediated signaling, suggesting that analogous compounds in E. ingens may have latency-reversing activity relevant to "shock and kill" HIV strategies.
**Antimicrobial Properties**
Extracts from multiple Euphorbia species, including E. ingens, display antimicrobial activity in preliminary in vitro screens, attributed to the combined action of diterpene esters and polyphenolic constituents that disrupt microbial membrane integrity.
**Ichthyocidal and Pest-Control Utility**
The latex demonstrates potent ichthyocidal (fish-killing) activity at controlled concentrations, reflecting broad membrane-active toxicity that communities have historically exploited for subsistence fishing rather than direct human therapeutic benefit.
**PKC Modulation**: Ingenane esters interact with the diacylglycerol-binding domain of protein kinase C isoforms, a mechanistic axis shared with phorbol esters, offering a potential pharmacological scaffold
at approximately one-tenth the potency of TPA — for research into PKC-dependent signaling diseases.
Origin & History
Natural habitat
Euphorbia ingens is a large, candelabra-shaped succulent tree native to the semi-arid and savanna regions of southern and eastern Africa, including South Africa, Zimbabwe, Mozambique, and Tanzania. It thrives in rocky hillsides, bushveld, and thornveld ecosystems at altitudes up to approximately 1,800 meters, tolerating drought and poor soils. The plant is not cultivated for commercial medicinal purposes; it grows wild and is harvested opportunistically for its caustic latex by local communities.
“Euphorbia ingens holds cultural significance across southern Africa as a landmark tree in sacred groves and homestead boundaries among Zulu, Shona, and Venda peoples, where it was traditionally considered protective against evil spirits as much as it was used medicinally. Its latex has been employed by various communities as a fish poison in rivers and rock pools — a practice documented in Zimbabwean and South African ethnobotanical surveys — exploiting its potent ichthyocidal properties for subsistence fishing. Medicinal applications recorded in regional ethnobotany include topical use of diluted latex for the treatment of warts, infected wounds, and skin parasites, though preparation knowledge was guarded by traditional healers and application was highly contextual and experience-dependent. The plant's imposing candelabra form has also earned it roles in traditional ecological knowledge as a living fence and drought-resistant boundary marker, reflecting its deep integration into the landscape management practices of semi-arid African communities.”Traditional Medicine
Scientific Research
The evidence base for Euphorbia ingens is limited exclusively to preclinical in vitro and animal studies with no registered or published human clinical trials as of the available literature. Mouse skin bioassays have characterized the relative irritancy and tumor-promoting activity of individual ingenane factors (I1, I5, I6), establishing structure-activity relationships but providing no translatable human dose-response data. A small number of in vitro cytotoxicity studies using E. ingens ethyl acetate fraction report an IC50 of 9.71 ± 0.4 µg/mL with a selectivity index of 8.26 against cancer cell lines, though sample sizes, cell line identities, and replicate numbers are inadequately reported in accessible literature. Extrapolation from related species (E. usambarica) suggests antiviral potential, but inter-species pharmacological equivalence has not been established, and the overall quality of the existing evidence is low by contemporary clinical standards.
Preparation & Dosage
Traditional preparation
**Traditional Crude Latex**
Applied topically by incising the stem or branch of the living plant to release white latex; used sparingly on wounds or skin infections in African folk practice — no safe dose is established and burns or ulceration are documented risks.
**Experimental Ethyl Acetate Extract**
0078–2 mg/mL to characterize cytotoxicity; no therapeutic preparation protocol exists for human use
Used in laboratory settings at concentrations of 0..
**Crude Latex Aqueous Dilution (Ichthyocidal Use)**
Latex diluted in water at unspecified field concentrations for temporary fish stunning; precise dilution ratios are not standardized and use is context-specific.
**No Standardized Supplement Form**
No capsule, tincture, powder, or topical pharmaceutical formulation of E. ingens is commercially approved or available; no standardization percentage for ingenane esters has been established.
**Related Pharmaceutical Analogue — Ingenol Mebutate**
A synthetic derivative of ingenol 3-angelate from E. peplus (not E. ingens) is approved as a topical gel at 0.015–0.05% for actinic keratosis; this is not interchangeable with E. ingens preparations and is cited only for mechanistic context.
Nutritional Profile
Euphorbia ingens is not a nutritional ingredient and contributes no meaningful dietary macronutrients, micronutrients, or bioavailable phytochemicals suitable for human consumption. Its latex is chemically dominated by irritant polyfunctional diterpene esters (ingenane-type: factors I1, I5, I6) and nonirritant analogues (I2, I4), with related Euphorbia latexes reported to contain up to 99.22% terpene-class compounds by weight in certain analyses. Polyphenols and flavonoids are detected in leaf and stem extracts of congener species and may be present in E. ingens at trace levels, contributing minor antioxidant activity, but these have not been quantified in E. ingens specifically. No vitamins, essential fatty acids, proteins, or fiber with nutritional utility are documented; the ingredient is pharmacologically active rather than nutritionally relevant, and internal ingestion is contraindicated.
How It Works
Mechanism of Action
The primary bioactive constituents of E. ingens latex — Euphorbia factors I1, I5, and I6, which are ingenane-type polyfunctional diterpene esters — mimic diacylglycerol and bind to the C1 regulatory domain of protein kinase C (PKC) isoforms, triggering downstream phosphorylation cascades that alter cell proliferation, differentiation, and inflammatory signaling. Factor I1 (3-hexadecanoate of ingenol) exhibits tumor-promoting activity in mouse skin assays at approximately one-tenth the potency of the reference phorbol ester TPA, while I5 and I6 are more potent irritants but weaker tumor promoters, indicating isoform-selective or context-dependent PKC engagement. PKC activation by these compounds likely promotes the transcription of nuclear factor-κB (NF-κB)-regulated genes, explaining both the pro-inflammatory irritancy and, paradoxically, the latency reversal of HIV-1 provirus observed in related species' ingenol fractions at low micromolar concentrations. The antiproliferative activity observed in cancer cell lines at IC50 9.71 µg/mL may involve PKC-mediated induction of apoptotic pathways or disruption of mitotic signaling, though the precise downstream effectors in E. ingens specifically have not been molecularly characterized.
Clinical Evidence
No human clinical trials of any design — randomized, observational, or compassionate use — have been conducted on Euphorbia ingens or its isolated constituents. Available preclinical data consist of mouse skin irritancy assays, uncharacterized in vitro antiproliferative assays, and ichthyocidal concentration-response studies, none of which meet the threshold for translating to human efficacy claims. Effect sizes from in vitro antiproliferative data (IC50 ~9.71 µg/mL, selectivity index 8.26) are preliminary signals that would require extensive pharmacokinetic, toxicological, and mechanistic validation before any clinical investigation could ethically proceed given the known high toxicity of the latex. Confidence in any therapeutic benefit for wound treatment, infection management, or anticancer application in humans is currently negligible, and the compound cannot be recommended for clinical use outside of controlled research contexts.
Safety & Interactions
Euphorbia ingens latex poses a high toxicity risk: direct skin contact causes severe irritation, inflammatory dermatitis, and potential ulceration due to PKC-activating ingenane esters, and ocular exposure may result in serious injury including keratitis and temporary or permanent vision impairment. In vitro data show significant cytotoxicity beginning at concentrations as low as 0.0078–0.031 mg/mL, and mouse assays confirm tumor-promoting activity with Euphorbia factors I5 and I6 being the most potent irritants. No formal drug interaction studies exist; however, given PKC activation as the primary mechanism, theoretical interactions with immunosuppressants, protein kinase inhibitors (e.g., midostaurin, ibrutinib), and chemotherapeutic agents warrant extreme caution. This ingredient is absolutely contraindicated for ingestion, use during pregnancy or lactation, application to broken or sensitive skin, and use in children; no maximum safe human dose has been established, and internal use in any form is not endorsed by any regulatory authority.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Euphorbia ingensCandelabra TreeNaboom (Afrikaans)Thorn EuphorbiaInhlaba (Zulu)
Frequently Asked Questions
Is Euphorbia ingens (ku tim) safe to use on wounds?
Euphorbia ingens latex is not safe for general wound application without expert guidance; it contains ingenane-type diterpene esters (Euphorbia factors I1, I5, I6) that are potent skin irritants capable of causing chemical burns, inflammatory dermatitis, and ulceration on direct contact. Although traditional African medicine records topical use on infected wounds, no clinical studies confirm safety or efficacy, and the caustic nature of the latex means it is as likely to damage tissue as to heal it. Medical wound care with evidence-based antiseptics is strongly preferred.
What are the active compounds in Euphorbia ingens latex?
The primary bioactive compounds in Euphorbia ingens latex are ingenane-type polyfunctional diterpene esters, specifically Euphorbia factor I1 (3-hexadecanoate of ingenol), Euphorbia factor I5 (16-angelate-3-deca-2,4,6-trienoate of 16-hydroxyingenol), and Euphorbia factor I6 (3-deca-2,4,6-trienoic acid ester of ingenol). Nonirritant compounds including ingenol-20-hexadecanoate (I2) and 3,7,12-triacetate-8-nicotinate of ingol (I4) are also present. These compounds share structural and mechanistic similarities with phorbol esters, acting on protein kinase C at roughly one-tenth the potency of TPA.
Has Euphorbia ingens been tested in clinical trials?
No human clinical trials have been conducted on Euphorbia ingens or any of its isolated constituents. Existing research consists entirely of preclinical in vitro cytotoxicity assays — which identified an IC50 of 9.71 ± 0.4 µg/mL against cancer cells — and mouse skin irritancy and tumor-promotion bioassays. The high toxicity of the latex makes advancing to human trials ethically challenging without substantial further safety profiling.
Is ku tim related to the approved drug ingenol mebutate?
Ku tim (Euphorbia ingens) is botanically related to Euphorbia peplus, the plant from which ingenol mebutate (Picato) — a topical drug approved for actinic keratosis at 0.015–0.05% — was derived. Both plants belong to the genus Euphorbia and contain ingenol-based diterpene esters acting via protein kinase C activation. However, ingenol mebutate is a chemically distinct, pharmaceutical-grade synthetic derivative not extracted from E. ingens, and the two should not be considered interchangeable in safety or efficacy.
What traditional uses does ku tim (Euphorbia ingens) have in African medicine?
In traditional southern and eastern African medicine, Euphorbia ingens latex has been used topically for wound treatment, skin infections, and wart removal, and the plant has been employed as an ichthyocide — a fish-stunning poison — in subsistence fishing practices documented among Zimbabwean and South African communities. The plant also holds cultural roles as a sacred boundary marker and protective tree in Zulu, Shona, and Venda traditions. Preparation typically involves direct latex extraction from incised stems, with application guided by traditional healers who possessed empirical knowledge of safe dilution and application contexts.
What is the bioavailability of Euphorbia ingens extracts, and which form is most effective for absorption?
The ethyl acetate fraction of E. ingens demonstrates the strongest in vitro antiproliferative activity with an IC50 of 9.71 ± 0.4 µg/mL, suggesting this extraction method may concentrate bioactive compounds. However, human bioavailability studies are lacking, and traditional use has primarily involved topical latex application rather than oral supplementation. The lipid-soluble nature of the latex suggests potential for dermal penetration, but oral bioavailability remains uncharacterized in clinical settings.
Does Euphorbia ingens interact with chemotherapy drugs or cancer medications?
Given that E. ingens latex demonstrates selective cytotoxicity against cancer cell lines in vitro with a selectivity index of 8.26, concurrent use with chemotherapy agents warrants caution due to potential additive or antagonistic effects. No formal drug interaction studies have been conducted between E. ingens and oncologic medications. Anyone considering this ingredient alongside cancer treatment should consult their oncologist before use.
Who should avoid Euphorbia ingens supplementation, and are there safety concerns for specific populations?
E. ingens is a latex-producing plant and should be avoided by individuals with latex allergies or sensitivities, as cross-reactivity is possible. Pregnant and nursing women should avoid this ingredient due to the absence of safety data and the traditional use of the latex as a purgative in African medicine. Children and individuals with gastrointestinal conditions should also avoid use without professional medical guidance, as the purgative properties and potent bioactive compounds pose unknown risks.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w ku-tim-euphorbia-ingens curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
